Concepedia

Georgios Georgakis

GG

32

Publications

2K

Citations

21

H-Index

1998

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Baylor College of Medicine

Stony Brook University

George Mason University

Stony Brook University Hospital

Georgios Georgakis is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pathology, and tumor biology.

ORCID

Top concepts

Publications per year

1998–2023

32

Publications

32

MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival

Bei Zheng, Paolo Fiumara, Yang V. Li et al. · Blood · 2003 · 210 citations · Full text

Activity of selective fully human agonistic antibodies to the TRAIL death receptors TRAIL‐R1 and TRAIL‐R2 in primary and cultured lymphoma cells: induction of apoptosis and enhancement of doxorubicin‐ and bortezomib‐induced cell death

Georgios Georgakis, Yang Li, Robin Humphreys et al. · British Journal of Haematology · 2005 · 169 citations

Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines

Daniela Buglio, Georgios Georgakis, Shino Hanabuchi et al. · Blood · 2008 · 159 citations · Full text

Temsirolimus downregulates p21 without altering cyclin D1 expression and induces autophagy and synergizes with vorinostat in mantle cell lymphoma

Victor Yazbeck, Daniela Buglio, Georgios Georgakis et al. · Experimental Hematology · 2008 · 139 citations

, , +9

Inhibition of Heat Shock Protein 90 Function by 17-Allylamino-17-Demethoxy-Geldanamycin in Hodgkin's Lymphoma Cells Down-Regulates Akt Kinase, Dephosphorylates Extracellular Signal–Regulated Kinase, and Induces Cell Cycle Arrest and Cell Death

Georgios Georgakis, Yang Li, Georgios Z. Rassidakis et al. · Clinical Cancer Research · 2006 · 122 citations

Rows per page

1–5 of 32